• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Live UK pricing:

Avacta Group PLC (AVCT)

ORD 10P
Sell: 65.00p|Buy: 66.00p|Change: 1.50 (2.34%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment

This investment is listed on the Alternative Investment Market (AIM). Investments on this market can be higher risk and have lower liquidity, meaning they can be harder to buy or sell, and their prices may be more volatile. Before investing, make sure you understand the risks of investing.

Company profile

Avacta Group PLC is a clinical-stage life sciences company expanding the reach of potent cancer therapies with the pre-CISION platform. pre-CISION is a proprietary warhead delivery system based on a tumor-specific protease (fibroblast activation protein or FAP) that is designed to concentrate potent warheads in the tumor microenvironment while sparing normal tissues. The company's pipeline consists of pre-CISION peptide drug conjugates (PDC) or Affimer drug conjugates (AffDC) that leverage the tumor-specific release mechanism, providing benefits over traditional antibody drug conjugates. The firm has one reportable segment, Therapeutics, which is engaged in the development of novel cancer therapies harnessingits proprietary technology. Geographically, it derives revenue from South Korea.

Address

Unit 20, Ash Way
Thorp Arch Estate
Wetherby
GBR
LS23 7FA

Telephone

+44 1904217070

Website

https://avacta.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Avacta Group PLC Second Quarter Earnings Results for 20272027-09-30T00:00:00
Avacta Group PLC Second Quarter Earnings Conference Call for 20272027-09-30T00:00:00
Avacta Group PLC Annual General Meeting for 20262027-06-22T08:00:00
Avacta Group PLC Annual Report for 20262027-05-28T00:00:00
Avacta Group PLC Fourth Quarter Earnings Conference Call for 20262027-05-19T13:00:00
Avacta Group PLC Fourth Quarter Earnings Results for 20262027-05-19T00:00:00

Previous key dates

NameKey Date
Avacta Group PLC Second Quarter Earnings Result for 20262026-09-30T00:00:00
Avacta Group PLC Second Quarter Earnings Conference Call for 20262026-09-30T00:00:00
Avacta Group PLC Annual General Meeting for 20252026-06-22T08:00:00
Avacta Group PLC Annual Report for 20252026-05-29T00:00:00
Avacta Group PLC Fourth Quarter Earnings Conference Call for 20252026-05-19T13:00:00
Avacta Group PLC Fourth Quarter Earnings Result for 20252026-05-19T00:00:00
46th Annual TD Cowen Health Care Conference2026-03-03T09:10:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.